|
시장보고서
상품코드
1872099
좌심실 보조장치(LVAD) : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)Left Ventricular Assist Device (LVAD) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
QYResearch
세계의 좌심실 보조장치(LVAD) 시장 규모는 2024년에 18억 4,500만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 9.2%로 확대하며, 2031년까지 34억 9,500만 달러에 달할 것으로 예측되고 있습니다.
이 보고서는 좌심보조장치(LVAD)의 국경을 초월한 산업 발자국, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재구축에 대한 최근 관세 조정과 국제적인 전략적 대응책에 대한 종합적인 평가를 제공합니다.
좌심실 보조장치(LVAD)는 외과적으로 이식하는 기계적 순환 보조장치로, 좌심실이 전신으로 혈액을 내보내는 것을 보조하는 장치입니다. 주로 심장 이식 대기 중인 중증 심부전 환자(이식 전 가교), 이식 적응증 외 환자(최종 치료) 또는 심장 회복을 위한 일시적 보조가 필요한 환자(회복 전 가교)에게 사용됩니다. LVAD는 펌프, 드라이브라인, 외부 컨트롤러 및 전원 공급 장치로 구성되어 중증 심부전 환자의 생존율과 삶의 질을 크게 향상시킬 수 있습니다.
좌심보조장치(LVAD) 시장은 주로 진행성 심부전 유병률 증가와 심장 이식 대기 환자 및 이식 대상에서 제외되는 환자 증가에 의해 주도되고 있습니다. 소형화 펌프, 연속 흐름 시스템, 배터리 수명 향상 등 LVAD 기술의 발전으로 장치 성능이 크게 향상되어 합병증 발생률이 감소하고 환자의 생존율과 삶의 질이 향상되었습니다. 또한 LVAD는 임상의와 환자들의 인식 확대, 선진국의 유리한 상환 정책과 함께 장기적인 치료 옵션으로 더 널리 채택되고 있습니다.
임상적 이점에도 불구하고 LVAD 시장은 몇 가지 문제에 직면해 있습니다. 중저소득 국가에서 접근을 제한하는 요인으로 높은 식재비용과 유지관리 비용을 들 수 있습니다. 감염, 혈전증, 출혈, 기기 고장 등 심각한 합병증 위험은 환자와 의료진 모두에게 여전히 심각한 우려 사항입니다. 또한 평생에 걸친 기기 관리의 필요성, 외부 전원에 대한 의존성, 수술 후 관리의 복잡성은 환자의 치료 순응도 및 치료 결과에 영향을 미칠 수 있습니다. 규제 장벽과 전문 수술센터의 제한적인 설치 상황도 보급 확대에 걸림돌이 되고 있습니다.
이 보고서는 세계의 좌심보조장치(LVAD) 시장에 대한 종합적인 분석을 제공하는 것을 목표로 합니다. 총판매량, 매출액, 가격, 주요 기업의 기업 점유율 및 순위에 초점을 맞추고, 지역별, 국가별, 유형별, 용도별 좌심보조장치(LVAD) 분석도 포함합니다.
이 보고서는 2024년을 기준 연도, 2020-2031년의 과거 데이터와 예측 데이터를 포함하여 판매량(대수) 및 매출액(백만 달러) 측면에서 좌심보조장치(LVAD) 시장 규모, 추정치 및 예측치를 제공했습니다. 정량적, 정성적 분석을 통해 독자들이 좌심실 보조장치(LVAD) 관련 사업 전략 및 성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 그리고 정보에 입각한 사업적 판단을 할 수 있도록 도와드립니다.
시장 세분화
기업별
- AbioMed
- Abbott(Thoratec)
- Medtronic(HeartWare)
- Berlin Heart
- Jarvik Heart
- Sun Medical Technology Research
- ReliantHeart
- CH Biomedical
유형별 부문
- BTT 요법
- DT(Destination Therapy)
- 기타
용도별 부문
- 병원
- 진료소
지역별
- 북미
- 미국
- 캐나다
- 아시아태평양
- 중국
- 일본
- 한국
- 동남아시아
- 인도
- 호주
- 기타 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 네덜란드
- 북유럽 국가
- 기타 유럽
- 라틴아메리카
- 멕시코
- 브라질
- 기타 라틴아메리카
- 중동 및 아프리카
- 튀르키예
- 사우디아라비아
- 아랍에미리트
- 기타 중동 및 아프리카
자주 묻는 질문
The global market for Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1845 million in 2024 and is forecast to a readjusted size of US$ 3495 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Left Ventricular Assist Device (LVAD) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
A Left Ventricular Assist Device (LVAD) is a mechanical circulatory support device that is surgically implanted to help the left ventricle pump blood to the rest of the body. It is primarily used in patients with advanced heart failure who are awaiting heart transplantation (bridge-to-transplant), not eligible for transplant (destination therapy), or need temporary support for heart recovery (bridge-to-recovery). The LVAD consists of a pump, a driveline, and an external controller and power source, and can significantly improve survival and quality of life in patients with severe cardiac dysfunction.
The Left Ventricular Assist Device (LVAD) market is primarily driven by the increasing prevalence of advanced heart failure and the growing number of patients who are either awaiting heart transplantation or are ineligible for transplant. Advances in LVAD technology-such as miniaturized pumps, continuous-flow systems, and improved battery life-have significantly enhanced device performance, reduced complication rates, and improved patient survival and quality of life. Additionally, expanding awareness among clinicians and patients, as well as favorable reimbursement policies in developed countries, are contributing to broader adoption of LVADs as a viable long-term treatment option.
Despite its clinical benefits, the LVAD market faces several challenges, including high costs of implantation and maintenance, which limit access in low- and middle-income countries. The risk of serious complications-such as infection, thrombosis, bleeding, and device malfunction-remains a significant concern for both patients and providers. Moreover, the need for lifelong device management, dependence on external power sources, and the complexity of post-operative care can affect patient adherence and outcomes. Regulatory hurdles and limited availability of specialized surgical centers also pose barriers to wider adoption.
This report aims to provide a comprehensive presentation of the global market for Left Ventricular Assist Device (LVAD), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Left Ventricular Assist Device (LVAD) by region & country, by Type, and by Application.
The Left Ventricular Assist Device (LVAD) market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Left Ventricular Assist Device (LVAD).
Market Segmentation
By Company
- AbioMed
- Abbott (Thoratec)
- Medtronic (HeartWare)
- Berlin Heart
- Jarvik Heart
- Sun Medical Technology Research
- ReliantHeart
- CH Biomedical
Segment by Type
- BTT Therapy
- Destination Therapy (DT)
- Other
Segment by Application
- Hospitals
- Clinics
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Left Ventricular Assist Device (LVAD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Left Ventricular Assist Device (LVAD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Left Ventricular Assist Device (LVAD) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Left Ventricular Assist Device (LVAD) Product Introduction
- 1.2 Global Left Ventricular Assist Device (LVAD) Market Size Forecast
- 1.2.1 Global Left Ventricular Assist Device (LVAD) Sales Value (2020-2031)
- 1.2.2 Global Left Ventricular Assist Device (LVAD) Sales Volume (2020-2031)
- 1.2.3 Global Left Ventricular Assist Device (LVAD) Sales Price (2020-2031)
- 1.3 Left Ventricular Assist Device (LVAD) Market Trends & Drivers
- 1.3.1 Left Ventricular Assist Device (LVAD) Industry Trends
- 1.3.2 Left Ventricular Assist Device (LVAD) Market Drivers & Opportunity
- 1.3.3 Left Ventricular Assist Device (LVAD) Market Challenges
- 1.3.4 Left Ventricular Assist Device (LVAD) Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Left Ventricular Assist Device (LVAD) Players Revenue Ranking (2024)
- 2.2 Global Left Ventricular Assist Device (LVAD) Revenue by Company (2020-2025)
- 2.3 Global Left Ventricular Assist Device (LVAD) Players Sales Volume Ranking (2024)
- 2.4 Global Left Ventricular Assist Device (LVAD) Sales Volume by Company Players (2020-2025)
- 2.5 Global Left Ventricular Assist Device (LVAD) Average Price by Company (2020-2025)
- 2.6 Key Manufacturers Left Ventricular Assist Device (LVAD) Manufacturing Base and Headquarters
- 2.7 Key Manufacturers Left Ventricular Assist Device (LVAD) Product Offered
- 2.8 Key Manufacturers Time to Begin Mass Production of Left Ventricular Assist Device (LVAD)
- 2.9 Left Ventricular Assist Device (LVAD) Market Competitive Analysis
- 2.9.1 Left Ventricular Assist Device (LVAD) Market Concentration Rate (2020-2025)
- 2.9.2 Global 5 and 10 Largest Manufacturers by Left Ventricular Assist Device (LVAD) Revenue in 2024
- 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Left Ventricular Assist Device (LVAD) as of 2024)
- 2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 BTT Therapy
- 3.1.2 Destination Therapy (DT)
- 3.1.3 Other
- 3.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Type
- 3.2.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Left Ventricular Assist Device (LVAD) Sales Value, by Type (2020-2031)
- 3.2.3 Global Left Ventricular Assist Device (LVAD) Sales Value, by Type (%) (2020-2031)
- 3.3 Global Left Ventricular Assist Device (LVAD) Sales Volume by Type
- 3.3.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2020 VS 2024 VS 2031)
- 3.3.2 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Type (2020-2031)
- 3.3.3 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Type (%) (2020-2031)
- 3.4 Global Left Ventricular Assist Device (LVAD) Average Price by Type (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Hospitals
- 4.1.2 Clinics
- 4.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Application
- 4.2.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Left Ventricular Assist Device (LVAD) Sales Value, by Application (2020-2031)
- 4.2.3 Global Left Ventricular Assist Device (LVAD) Sales Value, by Application (%) (2020-2031)
- 4.3 Global Left Ventricular Assist Device (LVAD) Sales Volume by Application
- 4.3.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2020 VS 2024 VS 2031)
- 4.3.2 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Application (2020-2031)
- 4.3.3 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Application (%) (2020-2031)
- 4.4 Global Left Ventricular Assist Device (LVAD) Average Price by Application (2020-2031)
5 Segmentation by Region
- 5.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Region
- 5.1.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2020-2025)
- 5.1.3 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2026-2031)
- 5.1.4 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (%), (2020-2031)
- 5.2 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region
- 5.2.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region: 2020 VS 2024 VS 2031
- 5.2.2 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2020-2025)
- 5.2.3 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2026-2031)
- 5.2.4 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (%), (2020-2031)
- 5.3 Global Left Ventricular Assist Device (LVAD) Average Price by Region (2020-2031)
- 5.4 North America
- 5.4.1 North America Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 5.4.2 North America Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
- 5.5 Europe
- 5.5.1 Europe Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 5.5.2 Europe Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
- 5.6 Asia Pacific
- 5.6.1 Asia Pacific Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 5.6.2 Asia Pacific Left Ventricular Assist Device (LVAD) Sales Value by Region (%), 2024 VS 2031
- 5.7 South America
- 5.7.1 South America Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 5.7.2 South America Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
- 5.8 Middle East & Africa
- 5.8.1 Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 5.8.2 Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value and Sales Volume
- 6.2.1 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 6.2.2 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Volume, 2020-2031
- 6.3 United States
- 6.3.1 United States Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 6.3.2 United States Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 6.4.2 Europe Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 6.5.2 China Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 6.6.2 Japan Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 6.7.2 South Korea Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 6.8.2 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
- 6.9.2 India Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 AbioMed
- 7.1.1 AbioMed Company Information
- 7.1.2 AbioMed Introduction and Business Overview
- 7.1.3 AbioMed Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 AbioMed Left Ventricular Assist Device (LVAD) Product Offerings
- 7.1.5 AbioMed Recent Development
- 7.2 Abbott (Thoratec)
- 7.2.1 Abbott (Thoratec) Company Information
- 7.2.2 Abbott (Thoratec) Introduction and Business Overview
- 7.2.3 Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Product Offerings
- 7.2.5 Abbott (Thoratec) Recent Development
- 7.3 Medtronic (HeartWare)
- 7.3.1 Medtronic (HeartWare) Company Information
- 7.3.2 Medtronic (HeartWare) Introduction and Business Overview
- 7.3.3 Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Product Offerings
- 7.3.5 Medtronic (HeartWare) Recent Development
- 7.4 Berlin Heart
- 7.4.1 Berlin Heart Company Information
- 7.4.2 Berlin Heart Introduction and Business Overview
- 7.4.3 Berlin Heart Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Berlin Heart Left Ventricular Assist Device (LVAD) Product Offerings
- 7.4.5 Berlin Heart Recent Development
- 7.5 Jarvik Heart
- 7.5.1 Jarvik Heart Company Information
- 7.5.2 Jarvik Heart Introduction and Business Overview
- 7.5.3 Jarvik Heart Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Jarvik Heart Left Ventricular Assist Device (LVAD) Product Offerings
- 7.5.5 Jarvik Heart Recent Development
- 7.6 Sun Medical Technology Research
- 7.6.1 Sun Medical Technology Research Company Information
- 7.6.2 Sun Medical Technology Research Introduction and Business Overview
- 7.6.3 Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Product Offerings
- 7.6.5 Sun Medical Technology Research Recent Development
- 7.7 ReliantHeart
- 7.7.1 ReliantHeart Company Information
- 7.7.2 ReliantHeart Introduction and Business Overview
- 7.7.3 ReliantHeart Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 ReliantHeart Left Ventricular Assist Device (LVAD) Product Offerings
- 7.7.5 ReliantHeart Recent Development
- 7.8 CH Biomedical
- 7.8.1 CH Biomedical Company Information
- 7.8.2 CH Biomedical Introduction and Business Overview
- 7.8.3 CH Biomedical Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 CH Biomedical Left Ventricular Assist Device (LVAD) Product Offerings
- 7.8.5 CH Biomedical Recent Development
8 Industry Chain Analysis
- 8.1 Left Ventricular Assist Device (LVAD) Industrial Chain
- 8.2 Left Ventricular Assist Device (LVAD) Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Left Ventricular Assist Device (LVAD) Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Left Ventricular Assist Device (LVAD) Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
